Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE

152.900
-5.100-3.23%
Volume:2.50M
Turnover:379.78M
Market Cap:214.21B
PE:-41.88
High:154.300
Open:154.300
Low:147.800
Close:158.000
Loading ...

BeiGene Gets FDA Approval for Tevimbra in Stomach-Esophagus Junction Cancer

MT Newswires Live
·
27 Dec 2024

BeiGene Stomach-Cancer Treatment Gets FDA Approval, Second in U.S.

Dow Jones
·
27 Dec 2024

BeiGene to Change Ticker Symbol to 'ONC', Reflecting Oncology Commitment

MT Newswires Live
·
23 Dec 2024

BeiGene, Ltd.'s (NASDAQ:BGNE) recent 15% pullback adds to one-year year losses, institutional owners may take drastic measures

Simply Wall St.
·
17 Dec 2024

JPMorgan Chase & Co's Short Position in Shares of Beigene Decreases to 1.66% on Dec. 11 From 2.42% - HKEX

THOMSON REUTERS
·
16 Dec 2024

BeiGene Enters Global Licensing Agreement with CSPC Zhongqi for Experimental Cancer Therapy

MT Newswires Live
·
13 Dec 2024

CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland

MT Newswires Live
·
13 Dec 2024

BeiGene Secures $400 Million Facility from China Merchants Bank

MT Newswires Live
·
11 Dec 2024

BeiGene Gains Overweight Rating from Morgan Stanley with $300 Price Target

GuruFocus
·
04 Dec 2024

Hong Kong Stocks End Week in Green; Mokingran Jewellery Gains 8% in Debut

MT Newswires Live
·
29 Nov 2024

BeiGene's Four Drugs Included in China's Medical Insurance Catalog; Shares Jump 5%

MT Newswires Live
·
29 Nov 2024

Stock Track | BeiGene Soars 5.97% as Oncology Products Gain Entry into China's Medical Insurance List

Stock Track
·
29 Nov 2024

BUZZ-BeiGene's H-shares hit 4-week peak on products inclusion in China drug catalog

Reuters
·
29 Nov 2024

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

Dow Jones
·
27 Nov 2024

BeiGene's Tevimbra Gets Approval From European Commission as Treatment for Cancer Patients

MT Newswires Live
·
27 Nov 2024

BeiGene's Gastric, Esophageal Cancer Treatment Gets EU Approval

Dow Jones
·
27 Nov 2024

BeiGene Proposes Name Change

MT Newswires Live
·
14 Nov 2024

BeiGene to Rename as BeOne Medicines

MT Newswires Live
·
14 Nov 2024

BeiGene Swings to Loss in Q3; Hong Kong Shares Slide 3%

MT Newswires Live
·
13 Nov 2024

BeiGene Swings to Q3 Net Loss, Revenue Rises

MT Newswires Live
·
12 Nov 2024